Photochemistry Department (Synthetic Unit), National Research Centre, Cairo, Egypt.
Chemistry Department, College of Science, Ha'il University, Ha'il, KSA.
J Enzyme Inhib Med Chem. 2021 Dec;36(1):504-516. doi: 10.1080/14756366.2020.1871335.
In the current study, new thienopyrimidine conjugates bearing 1,2,3-triazole core and different sugar moieties have been designed and synthesized by Cu(I)-catalysed click dipolar cycloaddition. The cytotoxic activity of the synthesised conjugates , , , and - was studied against HCT-116 and MCF-7 cell lines by the MTT assay. The triazole glycosides and provided significant cytotoxic activities against HCT-116 cell lines comparable to that of doxorubicin and other studied compounds. The cytotoxic behaviour against MCF-7 exhibited that all the investigated compounds were more potent than doxorubicin. Moreover, all screened targets were evaluated against mutant EGFR kinase type L858R and the results revealed that the acetylated 1,2,3-triazole glycosides - exhibited excellent EGFR inhibitory activity in comparison with gefitinib. Furthermore, molecular modelling studies were performed to investigate the binding affinity of the most active compounds to EGFR enzyme.
在本研究中,设计并合成了含有 1,2,3-三唑核心和不同糖部分的新型噻吩并嘧啶缀合物,通过 Cu(I)-催化点击二极环加成反应。通过 MTT 测定法研究了合成的缀合物、、、和对 HCT-116 和 MCF-7 细胞系的细胞毒性。三唑糖苷和对 HCT-116 细胞系表现出显著的细胞毒性活性,与阿霉素和其他研究化合物相当。对 MCF-7 的细胞毒性行为表明,所有研究的化合物都比阿霉素更有效。此外,所有筛选的靶标都针对突变型 EGFR 激酶 L858R 进行了评估,结果表明乙酰化 1,2,3-三唑糖苷和对 EGFR 具有优异的抑制活性与吉非替尼相比。此外,还进行了分子建模研究,以研究最活跃的化合物与 EGFR 酶的结合亲和力。